Xencor, Inc. (XNCR) Stock Price, News & Historical Data - TheStreet

Summary

Profile

Financials

Events

Ownership

Options

Symbol	Last	Change
XNCR	37.05	0.00 (0.00%)
NVAX	110.82	0.00 (0.00%)
BHC	27.08	0.00 (0.00%)
PEN	237.58	0.00 (0.00%)
UTHR	213.96	0.00 (0.00%)

Company Info

Industry	Biotechnology
Sector	Health Technology
Employees	202
CEO	Dr. Bassil I. Dahiyat

Address	111 West Lemon Avenue , Monrovia, CA 91016
Phone	1.626.305.5900
Website	www.xencor.com

Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Statement Summary

as of 4:00 ET PM 01/13/2022

Total Assets (MRQ)	697.3 M
Total Liabilities (MRQ)	78.4 M
Shareholders’ Equity (MRQ)	618.9 M
Total Revenue (Annual)	19.7 M
Net Income (Annual)	-40.2 M

Earnings And Estimates

as of 4:00 ET PM 01/13/2022

Current Qtr EPS Estimate	-0.65
Current FY EPS Estimate	-0.49
Long Term EPS Growth Estimate	74.10
Next Expected Earnings Date	3/1/2022

XNCR vs S&P 500

as of 01/13/2022

	Relative To S&P 500	XNCR
4 Weeks	n/a	n/a
12 Weeks	n/a	n/a
YTD	n/a	n/a

Earnings Surprises

as of 4:00 ET PM 01/13/2022

Fiscal Quarter	Estimate	Actual	Surprise
09/2021	-0.63	-0.69	+9.35%
06/2021	-0.59	0.87	-248.26%
03/2021	-0.67	-0.04	-94.05%
12/2020	-0.38	-0.24	-36.64%
09/2020	-0.22	-0.22	-1.63%
06/2020	-0.51	-0.61	+18.91%
03/2020	-0.40	-0.14	-65.36%
12/2019	-0.41	-0.47	+14.36%

Financial Strength

as of 4:00 ET PM 01/13/2022

Pre-Tax Margin	-204.19
Net Margin	-475.41
Operating Margin	-209.83
Return On Equity	-0.69
Return On Assets	-0.61
Inventory Turnover (TTM)	0.00
Sales Growth (MRQ)	34.61

Ratios

as of 4:00 PM ET 01/13/2022

Price/Earnings (TTM)	n/a
Price/Book (MRQ)	3.50
Price/Cash Flow (TTM)	0.00
Book Value (MRQ)	10.59
Quick Ratio (MRQ)	7.44
Current Ratio (MRQ)	7.44
Total Debt/Equity (MRQ)	0.06

Short Interest

as of 4:00 PM ET 01/14/2022

	% Short - 0.00%
	% Remaining Float - 100.00%

	Current	Last Month
Short Interest Date	n/a	n/a
Short Interest Shares	0	0
Short Interest Ratio	0.0	0.0

M Y M Y

Total Assets 0,0.00 0,0.00

Total Liabilities 0,0.00 0,0.00

Total Equity 0,0.00 0,0.00

M Y M Y

Total Revenue 0,0.00 0,0.00

EBT Exc.
Unusual Items 0,0.00 0,0.00

Net Income 0,0.00 0,0.00

M Y M Y

Cash from
Operations 0,0.00 0,0.00

Cash from
Activities 0,0.00 0,0.00

Cash from
Fin. Activities 0,0.00 0,0.00

Select Period

TOTAL ASSETS	TOTAL LIABILITIES	TOTAL EQUITY

Balance Sheet

	M Y
ASSETS
Cash And Equivalents	0,0.00
Receivables	0,0.00
Inventories	0,0.00
Other Current Assets	0,0.00
Total Current Assets	0,0.00
Property, Plant & Equipment, Gross	0,0.00
Accumulated Depreciation & Depletion	0,0.00
Property, Plant & Equipment, Net	0,0.00
Intangibles	0,0.00
Other Non-Current Assets	0,0.00
Total Non-Current Assets	0,0.00
TOTAL ASSETS	0,0.00
Liabilities & Shareholder Equity
Accounts Payable	0,0.00
Short Term Debt	0,0.00
Total Current Liabilities	0,0.00
Long Term Debt	0,0.00
Deferred Income Taxes	0,0.00
Other Non-Current Liabilities	0,0.00
Minority Interest	0,0.00
Total Non-Current Liabilities	0,0.00
Preferred Stock Equity	0,0.00
Common Stock Equity	0,0.00
Common Par	0,0.00
Additional Paid In Capital	0,0.00
Cumulative Translation Adjustment	0,0.00
Retained Earnings	0,0.00
Treasury Stock	0,0.00
Other Equity Adjustments	0,0.00
Total Capitalization	0,0.00
TOTAL EQUITY	0,0.00
TOTAL LIABILITIES & STOCK EQUITY	0,0.00
Total Common Shares Outstanding	0,0.00
Preferred Shares	0,0.00
Treasury Shares	0,0.00
Basic Weighted Shares Outstanding	0,0.00
Diluted Weighted Shares Outstanding	0,0.00
Number Of Employees	0,0.00
Number Of Part-Time Employees	0,0.00

Select Period

TOTAL REVENUES	EBT Excluding Unusual Items	NET INCOME

Income Statement

	M Y
Sales	0,0.00
Cost Of Sales	0,0.00
Gross Operating Profit	0,0.00
Selling, General, And Administrative Expenses	0,0.00
Research & Development	0,0.00
Operating Income Before D & A (EBITDA)	0,0.00
Depreciation & Amortization	0,0.00
Interest Income	0,0.00
Other Income - Net	0,0.00
Special Income / Charges	0,0.00
Total Income Before Interest Expenses (EBIT)	0,0.00
Interest Expense	0,0.00
Pre-Tax Income	0,0.00
Income Taxes	0,0.00
Minority Interest	0,0.00
Net Income From Continuing Operations	0,0.00
Net Income From Discontinued Operations	0,0.00
Net Income From Total Operations	0,0.00
Extraordinary Income/Losses	0,0.00
Income From Cum. Effect Of Acct. Change	0,0.00
Income From Tax Loss Carryforward	0,0.00
Other Gains / Losses	0,0.00
Total Net Income	0,0.00
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Preferred Dividends	0,0.00
Net Income Available To Common	0,0.00
Basic EPS From Continuing Ops.	0,0.00
Basic EPS From Discontinued Ops.	0,0.00
Basic EPS From Total Operations	0,0.00
Basic EPS From Extraordinary Inc.	0,0.00
Basic EPS From Cum Effect Of Accounting Change	0,0.00
Basic EPS From Tax Loss Carryf'd.	0,0.00
Basic EPS From Other Gains (Losses)	0,0.00
Basic EPS, Total	0,0.00
Basic Normalized Net Income/Share	0,0.00
EPS From Continuing Ops.	0,0.00
EPS From Discontinued Ops	0,0.00
EPS From Total Ops.	0,0.00
EPS From Extraord. Inc.	0,0.00
EPS From Cum Effect of Accounting Change	0,0.00
EPS From Tax Loss Carfd.	0,0.00
EPS From Other Gains (L)	0,0.00
EPS, Total	0,0.00
Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Dividends Paid Per Share	0,0.00

Select Period

CASH FROM OPERATIONS	CASH FROM INVESTING ACTIVITIES	CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

	M Y
Cash Flow From Operating Activities
Net Income (Loss)	0,0.00
Operating Gains/Losses	0,0.00
Gross Operating Profit	0,0.00
(Increase) Decrease In Receivables	0,0.00
(Increase) Decrease In Inventories	0,0.00
(Increase) Decrease In Other Current Assets	0,0.00
(Decrease) Increase In Other Current Liabilities	0,0.00
(Increase) Decrease In Other Working Capital	0,0.00
Other Non-Cash Items	0,0.00
Net Cash From Continuing Operations	0,0.00
Net Cash From Discontinued Operations	0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	0,0.00
Sale Of Property, Plant & Equipment	0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments	0,0.00
Purchases Of Property, Plant & Equipment	0,0.00
Acquisitions	0,0.00
Purchases Of Short-Term Investments	0,0.00
Other Cash From Investing Activities	0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	0,0.00
Issuance Of Debt	0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock	0,0.00
Repayment Of Long-Term Debt	0,0.00
Repurchase Of Capital Stock	0,0.00
Payment Of Cash Dividends	0,0.00
Other Financing Charges, Net	0,0.00
Net Cash From Financing Activities	0,0.00
Effect Of Exchange Rate Changes	0,0.00
Net Change In Cash & Cash Equivalents	0,0.00

Earnings Estimates

as of 4:00 ET PM 01/13/2022

	Current Qtr (12/2021)	Next Qtr (03/2022)
Consensus Estimate	$-0.65	$-0.72
# of Estimates	6	6
High Estimate	$-0.38	$-0.53
Low Estimate	$-0.76	$-0.87
Year Ago EPS	$-0.24	$-0.04
Year Over Year Growth Estimate	172.91%	1,567.02%

	Current Yr (12/2021)	Next Yr (12/2022)
Consensus Estimate	$-0.49	$-2.37
# of Estimates	6	12
High Estimate	$-0.24	$-0.75
Low Estimate	$-0.60	$-3.77
Year Ago EPS	$-1.21	$-0.49
Year Over Year Growth Estimate	-59.11%	378.67%

	Current Qtr (12/2021)	Next Qtr (03/2022)	Current Year (12/2021)	Next Year (12/2022)
Consensus Estimate	$-0.65	$-0.72	$-0.49	$-2.37
# of Estimates	6	6	6	12
High Estimate	$-0.38	$-0.53	$-0.24	$-0.75
Low Estimate	$-0.76	$-0.87	$-0.60	$-3.77
Year Ago EPS	$-0.24	$-0.04	$-1.21	$-0.49
Year Over Year Growth Estimate	172.91%	1,567.02%	-59.11%	378.67%

Insider Information Summary

as of 12/31/1969

	% Insiders - 0.72%
	% Remaining Total Shares - 99.28%

	Current	1 Month
Net Insider Transaction	-3.66 K	0.00
Shares Bought	0.00	0.00
Shares Sold	3.66 K	0.00

Insider Activity

Purchases

Sales

Options Exercised

Options Awarded

Transaction Date	Insider/Title	Transaction Type	Market Value	Shares	Average Price	Current Holdings

Learn to Trade Like a Pro

Master The Market with the Help of Our Financial Experts

SUBSCRIBE NOW

INVESTING

AIMT

By Tony Owusu

Feb 5, 2020 10:10 AM EST

Latest News

4 Stocks With Strong Technicals That You Should Watch

Jul 15, 2016 9:32 AM EDT

May 4, 2016 1:08 PM EDT

New Lifetime High Reached By WGL Holdings (WGL)

Dec 22, 2015 10:45 AM EST

Cutting Back on Rampant Discounts Is a Big Risk for Michael Kors

Nov 6, 2015 7:30 AM EST

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders

Jun 29, 2015 1:10 PM EDT

3 Basic Materials Stocks Driving The Sector Higher

Jun 16, 2015 11:00 AM EDT

Jun 15, 2015 11:00 AM EDT

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG

May 15, 2015 11:30 AM EDT

5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More

Feb 18, 2014 2:30 PM EST

Ariad Pharmaceutical's Iclusig May Relieve Shareholders' Pain: StockTwits

Jan 17, 2014 3:30 PM EST

Dec 9, 2013 7:00 AM EST

Recent Articles from TheStreet

Walmart Looks to Reduce Shopper Stress With Easy Reorder

INVESTING

WMT NKE GPS

Walmart files applications seeking trademarks for digital currency, software to manage cryptocurrency and other digital assets and for online retail services.

INVESTING

'We continue to see benefits from accumulated savings and an increasing push toward digital,' said Michael Miebach.

INVESTING

NBC DIS NFLX

New report details the increasing dominance of streaming, but live television endures.

Burger King offers curry-topped sandwiches in some markets.

INVESTING

QSR MCD

The fast-food giant modifies its menu to appeal to fans all over the world and sometimes that means offering something very bold.

Elon Musk, founder of Tesla and SpaceX, brought attention on the Clubhouse to new heights after hosting a conversation on the audio social app. Photo: AFP

INVESTING

TSLA

A Tesla lawyer asked law firm Cooley to fire an attorney who worked on a U.S. Securities and Exchange Commission investigation of Elon Musk, according to a Wall Street Journal report.